Log in

NASDAQ:OFIX - Orthofix Medical Stock Price, Forecast & News

$45.04
-0.32 (-0.71 %)
(As of 02/21/2020 04:00 PM ET)
Today's Range
$44.46
Now: $45.04
$45.48
50-Day Range
$43.24
MA: $45.18
$47.52
52-Week Range
$39.75
Now: $45.04
$74.44
Volume124,796 shs
Average Volume96,318 shs
Market Capitalization$858.46 million
P/E RatioN/A
Dividend YieldN/A
Beta0.46
Orthofix Medical Inc, a medical device company, provides musculoskeletal healing products and therapies worldwide. It operates through four segments: Bone Growth Therapies, Spinal Implants, Biologics, and Orthofix Extremities. The Bone Growth Therapies segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion and are indicated as treatment to enhance fusion success rates in cervical and lumbar spine, as well as a therapeutic treatment for non-spinal appendicular fractures. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:OFIX
CUSIPN6748L10
Phone214-937-2000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$453.04 million
Cash Flow$3.05 per share
Book Value$18.05 per share

Profitability

Net Income$13.81 million

Miscellaneous

Employees954
Market Cap$858.46 million
Next Earnings Date2/24/2020 (Confirmed)
OptionableOptionable

Receive OFIX News and Ratings via Email

Sign-up to receive the latest news and ratings for OFIX and its competitors with MarketBeat's FREE daily newsletter.


Orthofix Medical (NASDAQ:OFIX) Frequently Asked Questions

What is Orthofix Medical's stock symbol?

Orthofix Medical trades on the NASDAQ under the ticker symbol "OFIX."

How were Orthofix Medical's earnings last quarter?

Orthofix Medical Inc (NASDAQ:OFIX) released its quarterly earnings results on Monday, October, 28th. The medical device company reported $0.41 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.51 by $0.10. The medical device company had revenue of $113.50 million for the quarter, compared to the consensus estimate of $117.83 million. Orthofix Medical had a negative net margin of 6.81% and a positive return on equity of 9.16%. Orthofix Medical's revenue for the quarter was up 1.6% compared to the same quarter last year. During the same period last year, the company earned $0.44 earnings per share. View Orthofix Medical's Earnings History.

When is Orthofix Medical's next earnings date?

Orthofix Medical is scheduled to release their next quarterly earnings announcement on Monday, February 24th 2020. View Earnings Estimates for Orthofix Medical.

How can I listen to Orthofix Medical's earnings call?

Orthofix Medical will be holding an earnings conference call on Monday, February 24th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What price target have analysts set for OFIX?

2 brokers have issued twelve-month price targets for Orthofix Medical's shares. Their forecasts range from $48.00 to $48.00. On average, they expect Orthofix Medical's stock price to reach $48.00 in the next twelve months. This suggests a possible upside of 6.6% from the stock's current price. View Analyst Price Targets for Orthofix Medical.

What is the consensus analysts' recommendation for Orthofix Medical?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Orthofix Medical in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Orthofix Medical.

Has Orthofix Medical been receiving favorable news coverage?

Media stories about OFIX stock have trended very negative on Saturday, according to InfoTrie Sentiment. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Orthofix Medical earned a media sentiment score of -3.5 on InfoTrie's scale. They also gave press coverage about the medical device company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the next few days. View News Stories for Orthofix Medical.

Are investors shorting Orthofix Medical?

Orthofix Medical saw a decrease in short interest in January. As of January 31st, there was short interest totalling 316,400 shares, a decrease of 14.9% from the January 15th total of 371,800 shares. Based on an average daily volume of 146,900 shares, the short-interest ratio is currently 2.2 days. Currently, 1.7% of the company's stock are sold short. View Orthofix Medical's Current Options Chain.

Who are some of Orthofix Medical's key competitors?

What other stocks do shareholders of Orthofix Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Orthofix Medical investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Exxon Mobil (XOM), Clovis Oncology (CLVS), Esperion Therapeutics (ESPR), Gilead Sciences (GILD), iCAD (ICAD), Intercept Pharmaceuticals (ICPT), Madrigal Pharmaceuticals (MDGL) and Zogenix (ZGNX).

Who are Orthofix Medical's key executives?

Orthofix Medical's management team includes the folowing people:
  • Mr. Bradley R. Mason, Pres, CEO & Director (Age 65)
  • Mr. Douglas C. Rice, CFO & Chief Accounting Officer (Age 53)
  • Ms. Kimberley A. Elting, Chief Legal & Admin. Officer (Age 54)
  • Mr. Michael M. Finegan, Chief Strategy Officer (Age 55)
  • Mr. Davide Bianchi, Pres of Global Extremities (Age 54)

Who are Orthofix Medical's major shareholders?

Orthofix Medical's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Paradice Investment Management LLC (4.36%), State Street Corp (3.59%), Goldman Sachs Group Inc. (2.64%), Dalton Greiner Hartman Maher & Co. (2.23%), Renaissance Technologies LLC (1.94%) and Geode Capital Management LLC (1.65%). Company insiders that own Orthofix Medical stock include Brad Mason, Bradley V Niemann, Davide Bianchi, Kimberley A Elting, Luke T Faulstick, Rice Doug and Ronald A Matricaria. View Institutional Ownership Trends for Orthofix Medical.

Which major investors are selling Orthofix Medical stock?

OFIX stock was sold by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Victory Capital Management Inc., Marshall Wace LLP, Mackay Shields LLC, AJO LP, Renaissance Technologies LLC, SG Americas Securities LLC and Geode Capital Management LLC. View Insider Buying and Selling for Orthofix Medical.

Which major investors are buying Orthofix Medical stock?

OFIX stock was acquired by a variety of institutional investors in the last quarter, including Royce & Associates LP, Dalton Greiner Hartman Maher & Co., Bank of Montreal Can, Jacobs Levy Equity Management Inc., Great West Life Assurance Co. Can, Thrivent Financial for Lutherans, Paradice Investment Management LLC and Charles Schwab Investment Management Inc.. View Insider Buying and Selling for Orthofix Medical.

How do I buy shares of Orthofix Medical?

Shares of OFIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Orthofix Medical's stock price today?

One share of OFIX stock can currently be purchased for approximately $45.04.

How big of a company is Orthofix Medical?

Orthofix Medical has a market capitalization of $858.46 million and generates $453.04 million in revenue each year. The medical device company earns $13.81 million in net income (profit) each year or $1.96 on an earnings per share basis. Orthofix Medical employs 954 workers across the globe.View Additional Information About Orthofix Medical.

What is Orthofix Medical's official website?

The official website for Orthofix Medical is http://www.orthofix.com/.

How can I contact Orthofix Medical?

Orthofix Medical's mailing address is 3451 Plano Parkway, Lewisville TX, 75056. The medical device company can be reached via phone at 214-937-2000 or via email at [email protected]


MarketBeat Community Rating for Orthofix Medical (NASDAQ OFIX)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  360 (Vote Outperform)
Underperform Votes:  426 (Vote Underperform)
Total Votes:  786
MarketBeat's community ratings are surveys of what our community members think about Orthofix Medical and other stocks. Vote "Outperform" if you believe OFIX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OFIX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/22/2020 by MarketBeat.com Staff

Featured Article: Bid-Ask Spread

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel